83 related articles for article (PubMed ID: 8588402)
1. Resected esophageal squamous cell carcinoma.
Rodríguez-Sanjuán JC; Val-Bernal F
World J Surg; 1996 Jan; 20(1):115-6. PubMed ID: 8588402
[No Abstract] [Full Text] [Related]
2. Prognosis of early esophageal cancer: differences between squamous cell carcinoma and adenocarcinoma.
Bollschweiler E; Hölscher AH
Ann Surg; 2007 Feb; 245(2):334. PubMed ID: 17245190
[No Abstract] [Full Text] [Related]
3. The prognostic significance of lymph node micrometastasis in patients with esophageal carcinoma.
Incarbone R; Bonavina L
Cancer; 1999 Nov; 86(9):1883-5. PubMed ID: 10547564
[No Abstract] [Full Text] [Related]
4. [Esophageal carcinoma in an advanced stage. The value of surgery plus radiochemotherapy].
Theisen J; Siewert JR
MMW Fortschr Med; 2002 Jul; 144(27-28):36-8. PubMed ID: 12198876
[No Abstract] [Full Text] [Related]
5. pT2N0M0 esophageal squamous cell cancer: location, grade, and statistics.
Rice TW; Blackstone EH
J Thorac Cardiovasc Surg; 2013 Jun; 145(6):1426-7. PubMed ID: 23499471
[No Abstract] [Full Text] [Related]
6. Reduced nuclear and ectopic cytoplasmic expression of lysyl oxidase-like 2 is associated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.
Li TY; Xu LY; Wu ZY; Liao LD; Shen JH; Xu XE; Du ZP; Zhao Q; Li EM
Hum Pathol; 2012 Jul; 43(7):1068-76. PubMed ID: 22204712
[TBL] [Abstract][Full Text] [Related]
7. Does lymphadenectomy add anything to the treatment of esophageal cancer?
Law S; Wong J
Adv Surg; 1999; 33():311-27. PubMed ID: 10572574
[No Abstract] [Full Text] [Related]
8. Clinicopathological and prognostic significance of EGFR over-expression in esophageal squamous cell carcinoma: a meta-analysis.
Yu WW; Guo YM; Zhu M; Cai XW; Zhu ZF; Zhao WX; Fu XL
Hepatogastroenterology; 2011; 58(106):426-31. PubMed ID: 21661408
[TBL] [Abstract][Full Text] [Related]
9. The clinicopathological significance of p21 and p53 expression in esophageal squamous cell carcinoma: an analysis of 153 patients.
Lam KY; Law S; Tin L; Tung PH; Wong J
Am J Gastroenterol; 1999 Aug; 94(8):2060-8. PubMed ID: 10445528
[TBL] [Abstract][Full Text] [Related]
10. [Squamous cell cancer of the esophagus. Treatment concept at the National Cancer Center in Tokyo].
Watanabe H
Chirurg; 1992 Sep; 63(9):689-92. PubMed ID: 1395873
[No Abstract] [Full Text] [Related]
11. Therapeutic value of lymph node dissection for esophageal squamous cell carcinoma after neoadjuvant chemotherapy.
Miyata H; Yamasaki M; Makino T; Miyazaki Y; Takahashi T; Kurokawa Y; Nakajima K; Takiguchi S; Mori M; Doki Y
J Surg Oncol; 2015 Jul; 112(1):60-5. PubMed ID: 26179950
[TBL] [Abstract][Full Text] [Related]
12. Prognostic implication of proliferative markers MIB-1 and PC10 in esophageal squamous cell carcinoma.
Lam KY; Law SY; So MK; Fok M; Ma LT; Wong J
Cancer; 1996 Jan; 77(1):7-13. PubMed ID: 8630942
[TBL] [Abstract][Full Text] [Related]
13. Do tumor grade and location affect survival in esophageal squamous cell carcinoma? Survival analysis of 302 cases of pT3N0M0 esophageal squamous cell carcinoma.
Situ D; Wei W; Lin P; Long H; Zhang L; Fu J; Rong T; Ma G
Ann Surg Oncol; 2013 Feb; 20(2):580-5. PubMed ID: 23015029
[TBL] [Abstract][Full Text] [Related]
14. Endoscopic tumor length is an independent prognostic factor in esophageal squamous cell carcinoma.
Wang BY; Liu CY; Lin CH; Hsu PK; Hsu WH; Wu YC; Cheng CY
Ann Surg Oncol; 2012 Jul; 19(7):2149-58. PubMed ID: 22407313
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical and oncogenetic analyses of the esophageal basaloid squamous cell carcinoma in comparison with conventional squamous cell carcinomas.
Imamhasan A; Mitomi H; Saito T; Hayashi T; Takahashi M; Kajiyama Y; Yao T
Hum Pathol; 2012 Nov; 43(11):2012-23. PubMed ID: 22607702
[TBL] [Abstract][Full Text] [Related]
16. Lack of fludeoxyglucose F 18 uptake in posttreatment positron emission tomography as a significant predictor of survival after subsequent surgery in multimodality treatment for patients with locally advanced esophageal squamous cell carcinoma.
Higuchi I; Yasuda T; Yano M; Doki Y; Miyata H; Tatsumi M; Fukunaga H; Takiguchi S; Fujiwara Y; Hatazawa J; Monden M
J Thorac Cardiovasc Surg; 2008 Jul; 136(1):205-12, 212.e1-3. PubMed ID: 18603077
[TBL] [Abstract][Full Text] [Related]
17. [Prognostic evaluation of squamous cell carcinoma of the esophagus].
Kolosov AE; Dovgaliuk AZ; Stoliarov VI
Sov Med; 1991; (10):68-9. PubMed ID: 1801242
[No Abstract] [Full Text] [Related]
18. Endosonographic assessment of multimodality therapy predicts survival of oesophageal carcinoma patients.
Eloubeidi MA; Wallace MB
Gastrointest Endosc; 2001 Jul; 54(1):132-4. PubMed ID: 11447984
[No Abstract] [Full Text] [Related]
19. Association of NY-ESO-1 expression with T cell infiltration in the tumor microenvironment of esophageal squamous cell carcinoma and survival.
Murakami Y
Hokkaido Igaku Zasshi; 2013 Apr; 88(2-3):71-9. PubMed ID: 23720902
[No Abstract] [Full Text] [Related]
20. [Factors influencing the prognosis of patients with squamous cell carcinoma of the esophagus. Correlation of the morphology of 100 surgical specimens and the postoperative life-span (author's transl)].
Sun SQ; Wu X
Zhonghua Zhong Liu Za Zhi; 1980; 2(2):119-24. PubMed ID: 7418599
[No Abstract] [Full Text] [Related]
[Next] [New Search]
